Prospera Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.42M | Buy |
14,133
+10,320
| +271% | +$5.42M | 0.14% | 161 |
|
|
2025
Q1 | $2.42M | Buy |
3,813
+115
| +3% | +$72.9K | 0.06% | 349 |
|
|
2024
Q4 | $2.63M | Buy |
3,698
+2,958
| +400% | +$2.11M | 0.06% | 314 |
|
|
2024
Q3 | $778K | Buy |
+740
| New | +$778K | 0.02% | 577 |
|
|
2023
Q1 | – | Sell |
-600
| Closed | -$433K | – | 995 |
|
|
2022
Q4 | $433K | Buy |
+600
| New | +$433K | 0.02% | 573 |
|
|
2022
Q3 | – | Sell |
-70
| Closed | -$41K | – | 1412 |
|
|
2022
Q2 | $41K | Buy |
70
+2
| +3% | +$1.17K | ﹤0.01% | 1073 |
|
|
2022
Q1 | $47K | Buy |
+68
| New | +$47K | ﹤0.01% | 1404 |
|
|
2020
Q4 | – | Sell |
-141
| Closed | -$79K | – | 1354 |
|
|
2020
Q3 | $79K | Sell |
141
-1,262
| -90% | -$707K | 0.03% | 477 |
|
|
2020
Q2 | $875K | Sell |
1,403
-624
| -31% | -$389K | 0.08% | 253 |
|
|
2020
Q1 | $990K | Buy |
+2,027
| New | +$990K | 0.11% | 204 |
|